Monday, December 23, 2024
HomeTagsPhase 1 Development

Phase 1 Development

Fusion Pharmaceuticals Announces Nomination of First Targeted Alpha Therapy Candidate in Collaboration with AstraZeneca

Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, announced nomination of the first targeted alpha therapy (TAT)...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics